Back to Search Start Over

Management of Knee Osteoarthritis

Authors :
Dmitriy Cherny
Joel A. Block
Source :
Rheumatic Disease Clinics of North America. 48:549-567
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

Knee osteoarthritis (OA) is a common and morbid condition. No disease-modifying therapies exist; hence the goals of current treatment are to palliate pain and to retain function. OA is significantly influenced by the placebo effect. Nonpharmacologic interventions are essential and have been shown to improve outcomes. Canes, unloading braces, and therapeutic heating/cooling may be valuable. Pharmacotherapy options include topical and oral nonsteroidal anti-inflammatory drugs, duloxetine, and periodic intra-articular glucocorticoids and hyaluronans. Opioids, intra-articular stem cells, and platelet-rich plasma are not recommended. Novel targets such as nerve growth factor are under investigation and may be approved soon for OA pain.

Details

ISSN :
0889857X
Volume :
48
Database :
OpenAIRE
Journal :
Rheumatic Disease Clinics of North America
Accession number :
edsair.doi.dedup.....fcc4d88f8be63a19bdcb8dacc13d8967
Full Text :
https://doi.org/10.1016/j.rdc.2022.02.011